Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Safety concerns and risk management of multiple sclerosis therapies
P. Soelberg Sorensen
*
*
Corresponding author for this work
Department of Clinical Medicine
39
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Safety concerns and risk management of multiple sclerosis therapies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Alemtuzumab
13%
Daclizumab
15%
Dimethyl Fumarate
30%
Fingolimod Hydrochloride
13%
Glatiramer Acetate
14%
Injections
5%
Interferons
9%
Intramuscular Injections
11%
Multiple Sclerosis
70%
Natalizumab
14%
Neurologists
11%
Patient Selection
8%
Pharmaceutical Preparations
28%
Relapsing-Remitting Multiple Sclerosis
24%
Risk Assessment
16%
Risk Management
86%
Safety
5%
Safety Management
100%
Subcutaneous Injections
10%
teriflunomide
33%
Therapeutics
12%